Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) announced they have reached an agreement with the European Commission (EC) to amend their originally agreed contractual delivery schedules for the Pfizer-BioNTech COVID-19 Vaccine.
Pfizer and BioNTech provide update on COVID-19 vaccine supply agreement with European Commission
May 16, 2022
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022